Skip to main content
. 2020 May 6;128(5):057002. doi: 10.1289/EHP5444

Table 1.

Outcome description in the study samples from the participating studies.

Study Country Test Age of assessment (y) Evaluator Cases [n (%)] Non-cases (n) Years of cohort enrollment
INUENDO-Greenland Greenland SDQ 7–8 Parents 31 (6.0) 487 2002–2004
INUENDO-Ukraine Ukraine SDQ 7–8 Parents 26 (5.4) 459 2002–2004
PCB cohort Slovakia CBCL-ADHD 4 Parents 10 (5.4) 175 2000–2002
HUMIS Norway NPR 10 Medical doctor 23 (2.3) 966 2002–2009
DNBC Denmark SDQ 7 Parents 42 (4.6) 872 1996–2002
FETOTOXa Denmark DNHR, DPCR 11 Medical doctor 215 (28.3) 544 1996–2002
INMA-Valencia Spain ADHD-DSM-IV 4–5 Teachers 27 (7.3) 344 2004–2005
INMA-Sabadell Spain ADHD-DSM-IV 4–5 Teachers 18 (4.8) 360 2004–2007
INMA-Gipuzkoa Spain ADHD-DSM-IV 4–5 Teachers 7 (3.1) 220 2006–2008

Note: ADHD-DSM-IV, ADHD Criteria of Diagnostic and Statistical Manual of Mental Disorders, 4th ed.; CBC-ADHD, attention syndrome scale of the Child Behavior Checklist; DNBC, Danish National Birth Cohort; DNHR, Danish National Hospital Registry; DPCR, Danish Psychiatric Central Registry; HUMIS, Norwegian Human Milk Study; INMA, Infancia y Medio Ambiente; NPR, Norwegian patient register; PCB, polychorinated biphenyl; SDQ, Strengths and Difficulties Questionnaire.

a

Observations in FETOTOX were selected using case–cohort sampling.